| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |